Category Archives: News and Events

BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021

• Clinical and pathological findings from clinical trial of the Bria-IMT™ regimen alone and in ...

BriaCell Announces Closing of US$25 Million Public Offering

BERKELEY, Calif. and VANCOUVER, British Columbia, February 26, 2021— BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, ...

BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing

BERKELEY, Calif. and VANCOUVER, British Columbia, February 23, 2021— BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, ...

BriaCell Presents Clinical Data at 2021 Keystone Symposium

Clinical and pathological findings presented from the clinical trials of Bria-IMT™ alone or in combination ...

BriaCell Announces Presentation at the 2021 Keystone Symposia Conference: Emerging Cell Therapies

• Clinical and pathological data from clinical trial of the Bria-IMT™ regimen alone or in ...

BriaCell Presents Clinical Data at the 2020 San Antonio Breast Cancer Symposium®

Disease control and survival data is presented from the clinical trials of Bria-IMT™ alone or ...

BriaCell Appoints Martin Schmieg to Board of Directors

BERKELEY, Calif., and VANCOUVER, British Columbia, Dec. 1, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BRIACELL THERAPEUTICS CORP. CLOSES DEBT FINANCING

BERKELEY, Calif., and VANCOUVER, British Columbia, November 17, 2020 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Collaboration with the National Cancer Institute

• BriaCell and National Cancer Institute to collaborate on Bria-OTS™, BriaCell’s off-the-shelf personalized immunotherapy, as ...

BriaCell Breast Cancer Survival Data: 13.3 Months Versus 7.2-9.8 Months

• Overall Survival of 13.3 months in patients, including 14 months in patients with Grade ...